Effect of Vitamin B2 supplementation on migraine prophylaxis: a systematic review and meta-analysis

References

• Headache Classification Committee of The International Headache Society (IHS). The international classification of headache disorders, (beta version). Cephalalgia. 2013;33(9):629–808.
   PubMed Web of Science ®Google Scholar
• Sujan MU, Rao MR, Kisan R, Abhishekh HA. Influence of hydrotherapy on clinical and cardiac autonomic function in migraine patients. J Neurosci Rural Pract. 2016;7(1):109–13.
   PubMed Web of Science ®Google Scholar
• Menken M, Munsat TL, Toole JF. The global Burden of disease study. Arch Neurol. 2000;57(3):418–20.
   PubMed Web of Science ®Google Scholar
• Woldeamanuel YW, Cowan RP. Migraine affects 1 in 10 people worldwide featuring recent rise: a systematic review and meta-analysis of community-based studies involving 6 million participants. J Neurol Sci. 2017;372:307–15.
   PubMed Web of Science ®Google Scholar
• Woldeamanuel Y, Cowan R. (2016). Worldwide migraine epidemiology: systematic review and meta-analysis of 302 community-based studies involving 6,216,995 participants (P6. 100).
   Google Scholar
• Leonardi M, Raggi A. Burden of migraine: international perspectives. Neurol Sci 2013;34(Suppl 1):S117–8.
   PubMed Web of Science ®Google Scholar
• Silberstein SD, Winner PK, Chmiel JJ. Migraine preventive medication reduces resource utilization. Headache: J Head Face Pain. 2003;43(3):171–8.
   PubMed Web of Science ®Google Scholar
• Silberstein SD, Feliu AL, Rupnow MF, Blount AC, Boccuzzi SJ. Topiramate in migraine prophylaxis: long-term impact on resource utilization and cost. Headache: J Head Face Pain. 2007;47(4):500–10.
   PubMed Web of Science ®Google Scholar
• Silberstein SD. Preventive migraine treatment. Continuum Lifelong Learn Neurol. 2015;21(4 Headache):973–89.
   Google Scholar
• Mitsikostas DD, Rapoport AM. New players in the preventive treatment of migraine. BMC Med. 2015;13(1):279.
   PubMedGoogle Scholar
• Lipton RB, Bigal ME, Diamond M, Freitag F, Reed ML, Stewart WF. Migraine prevalence, disease burden, and the need for preventive therapy. Neurology. 2007;68(5):343–9.
   PubMed Web of Science ®Google Scholar
• Friedman MH, Peterson SJ, Behar CF, Zaidi Z. Intraoral chilling versus oral sumatriptan for acutemigraine. Heart Dis. 2001;3(6):357–61.
   PubMedGoogle Scholar
• Wallace DC. Mitochondrial defects in neurodegenerative disease. Ment Retard Dev Disabil Res Rev. 2001;7(3):158–66.
   PubMedGoogle Scholar
• Stuart S, Griffiths LR. A possible role for mitochondrial dysfunction in migraine. Mol Genet Genomics. 2012;287(11-12):837–44.
   PubMed Web of Science ®Google Scholar
• Colombo B, Saraceno L, Comi G. Riboflavin and migraine: the bridge over troubled mitochondria. Neurol Sci. 2014;35(1):141–4.
   PubMedGoogle Scholar
• Moher D, Liberati A, Tetzlaff J, Altman DG, Prisma Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097.
   PubMed Web of Science ®Google Scholar
• Namazi N, Heshmati J, Tarighat-Esfanjani A. Supplementation with Riboflavin (Vitamin B2) for migraine prophylaxis in adults and children: a review. Int J Vitam Nutr Res. 2015;85(1-2):79–87.
   PubMed Web of Science ®Google Scholar
• Rehman T, Ahmad S, Fatima Q. Effects of dietary supplementations and herbs on migraine - a systematic review. J Complement Integr Med. 2019;16(3):1–11.
   Google Scholar
• Thompson D, Saluja H. Prophylaxis of migraine headaches with riboflavin: a systematic review. J Clin Pharm Ther. 2017;42(4):394–403.
   PubMed Web of Science ®Google Scholar
• Breen C, Crowe A, Roelfsema HJ, Saluja IS. High-dose riboflavin for prophylaxis of migraine. Can Fam Physician. 2003;49:1291–3.
   PubMed Web of Science ®Google Scholar
• Gaul C, Diener H-C, Danesch U. Improvement of migraine symptoms with a proprietary supplement containing riboflavin, magnesium and Q10: a randomized, placebo-controlled, double-blind, multicenter trial. J Headache Pain. 2015;16:516.
   PubMed Web of Science ®Google Scholar
• Maizels M, Blumenfeld A, Burchette R. A combination of riboflavin, magnesium, and feverfew for migraine prophylaxis: a randomized trial. Headache. 2004;44(9):885–90.
   PubMed Web of Science ®Google Scholar
• Nambiar NJ, Aiyappa C, Srinivasa R. Oral riboflavin versus oral propranolol in migraine prophylaxis: an open label randomized controlled trial. Neurol Asia. 2011;16(3):223–229.
   Web of Science ®Google Scholar
• Rahimdel A, et al. Effectiveness of Vitamin B2 versus sodium valproate in migraine prophylaxis: a randomized clinical trial. Electron Physician. 2015;7(6):1344–8.
   PubMedGoogle Scholar
• Sándor PS, Afra J, Ambrosini A, Schoenen J. Prophylactic treatment of migraine with β-blockers and riboflavin: differential effects on the intensity dependence of auditory evoked cortical potentials. Headache: J Head Face Pain. 2000;40(1):30–35.
   PubMed Web of Science ®Google Scholar
• Schoenen J, Jacquy J, Lenaerts M. Effectiveness of high-dose riboflavin in migraine prophylaxis. A randomized controlled trial. Neurology. 1998;50(2):466–70.
   PubMed Web of Science ®Google Scholar
• Schoenen J, Lenaerts M, Bastings E. High-dose riboflavin as a prophylactic treatment of migraine: results of an open pilot study. Cephalalgia. 1994;14(5):328–9.
   PubMed Web of Science ®Google Scholar
• Boehnke C, Reuter U, Flach U, Schuh-Hofer S, Einhaupl KM, Arnold G. High-dose riboflavin treatment is efficacious in migraine prophylaxis: an open study in a tertiary care centre. Eur J Neurol. 2004;11(7):475–7.
   PubMed Web of Science ®Google Scholar
• Blumenfeld H. Neuroanatomy through clinical cases. 2nd ed. pp. 139–41. Sunderland: Sinauer Associates; 2010.
   Google Scholar
• Kristoffersen ES, Lundqvist C. Medication-overuse headache: epidemiology, diagnosis and treatment. Ther Adv Drug Saf. 2014;5(2):87–99.
   PubMedGoogle Scholar
• Gorman GS, Chinnery PF, DiMauro S, Hirano M, Koga Y, McFarland R, et al. Mitochondrial diseases. Nat Rev Dis Primers. 2016;2(1):1–22.
   Google Scholar
• Daniel O, Mauskop A. Nutraceuticals in acute and prophylactic treatment of migraine. Curr Treat Options Neurol. 2016;18(4):14.
   PubMed Web of Science ®Google Scholar
• Henriques B, Lucas GT, Gomes MC. Therapeutic approaches using riboflavin in mitochondrial energy metabolism disorders. Curr Drug Targets. 2016;17(13):1527–34.
   PubMed Web of Science ®Google Scholar
• The Cochrane Taiwan. Is Vitamin B2 effective in preventing migraine in adults? Evidence-based clinical practice guidelines for pain management. 2020: 30–31. Available from: https://taiwan.cochrane.org/news/%E5%AF%A6%E8%AD%89%E7%96%BC%E7%97%9B%E8%87%A8%E5%BA%8A%E7%85%A7%E8%AD%B7%E6%8C%87%E5%BC%95.
   Google Scholar
• Bolay H, Ozge A, Saginc P, Orekici G, Uludüz D, Yalın O, et al. Gender influences headache characteristics with increasing age in migraine patients. Cephalalgia. 2015;35(9):792–800.
   PubMed Web of Science ®Google Scholar
• Victor TW, Hu X, Campbsell JC, Buse DC, Lipton RB. Migraine prevalence by age and sex in the United States: a life-span study. Cephalalgia. 2010;30(9):1065–72.
   PubMed Web of Science ®Google Scholar
• Dogan VB, Dagdeviren H, Dirican A, Dirican AC, Tutar NK, Yayla VA, Cengiz H. Hormonal effect on the relationship between migraine and female sexual dysfunction. Neurol Sci. 2017;38(9):1651–5.
   PubMed Web of Science ®Google Scholar
• Avona A, Burgos-Vega C, Burton MD, Akopian AN, Price TJ, Dussor G. Dural calcitonin gene-related peptide produces female-specific responses in rodent migraine models. J Neurosci. 2019;39(22):4323–31.
   PubMed Web of Science ®Google Scholar
• Vetvik KG, MacGregor EA. Sex differences in the epidemiology, clinical features, and pathophysiology of migraine. Lancet Neurol. 2017;16(1):76–87.
   PubMed Web of Science ®Google Scholar
• Chong CD, Dumkrieger GM, Schwedt TJ. Structural co-variance patterns in migraine: A cross-sectional study exploring the role of the hippocampus. Headache: J Head Face Pain. 2017;57(10):1522–31.
   PubMed Web of Science ®Google Scholar
• Liu HY, Chou KH, Chen WT. Migraine and the hippocampus. Curr Pain Headache Rep. 2018;22(2):13.
   PubMed Web of Science ®Google Scholar
• Maleki N, Becerra L, Brawn J, McEwen B, Burstein R, Borsook D. Common hippocampal structural and functional changes in migraine. Brain Struct Funct. 2013;218(4):903–12.
   PubMed Web of Science ®Google Scholar